RMRP and metabolic dysfunction-associated steatotic liver disease: RMRP inhibition improved the pathological condition and liver function indices associated with lipid accumulation in the hepatic tissues of rats with NAFLD while alleviating steatosis and reducing triglyceride secretion in AML-12 cells treated with free fatty acids (FFAs).